品牌 | 货号 | 包装单位 | 货期 | CAS | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|---|
阿拉丁 | A127694-5mg | 5mg | 现货 | 1202757-89-8 |
AVL-292 AVL-292 |
Moligand™, ≥98% |
|
|
阿拉丁 | A127694-10mg | 10mg | 现货 | 1202757-89-8 |
AVL-292 AVL-292 |
Moligand™, ≥98% |
|
|
阿拉丁 | A127694-50mg | 50mg | 现货 | 1202757-89-8 |
AVL-292 AVL-292 |
Moligand™, ≥98% |
|
|
阿拉丁 | A127694-100mg | 100mg | 期货,请咨询 | 1202757-89-8 |
AVL-292 AVL-292 |
Moligand™, ≥98% |
|
|
阿拉丁 | A420893-1ml | 1ml | 现货 | 1202757-89-8 |
AVL-292 AVL-292 |
Moligand™, 10mM in DMSO |
|
|
麦克林 | A833081-10mg | 10mg | 订前询问 | 1202757-89-8 |
AVL-292 AVL-292 |
0.98 |
|
|
麦克林 | A833081-5mg | 5mg | 订前询问 | 1202757-89-8 |
AVL-292 AVL-292 |
0.98 |
|
|
罗恩 | R019181-5mg | 5mg | 现货 | 1202757-89-8 |
N-[3-[[5-氟-2-[[4-(2-甲氧基乙氧基)苯... N-[3-[[5-fluoro-2-[4-(2-meth... |
98% |
|
|
罗恩 | R019181-10mg | 10mg | 现货 | 1202757-89-8 |
N-[3-[[5-氟-2-[[4-(2-甲氧基乙氧基)苯... N-[3-[[5-fluoro-2-[4-(2-meth... |
98% |
|
|
MARY | MR1210292-10mg | 10mg | 订前咨询 | 1202757-89-8 |
N-[3-[[5-氟-2-[[4-(2-甲氧基乙氧基)苯... N-[3-[[5-fluoro-2-[4-(2-meth... |
98% |
|
|
MARY | MR1210292-5mg | 5mg | 订前咨询 | 1202757-89-8 |
N-[3-[[5-氟-2-[[4-(2-甲氧基乙氧基)苯... N-[3-[[5-fluoro-2-[4-(2-meth... |
98% |
|
|
源叶 | S41394-5mg | 5mg | 期货,请咨询 | 1202757-89-8 |
AVL-292 AVL-292 |
≥98% |
|
|
源叶 | S41394-10mg | 10mg | 期货,请咨询 | 1202757-89-8 |
AVL-292 AVL-292 |
≥98% |
|
|
源叶 | S41394-50mg | 50mg | 期货,请咨询 | 1202757-89-8 |
AVL-292 AVL-292 |
≥98% |
|
|
源叶 | S41394-100mg | 100mg | 期货,请咨询 | 1202757-89-8 |
AVL-292 AVL-292 |
≥98% |
|
|
源叶 | T88229-1ml | 1ml | 期货,请咨询 | 1202757-89-8 |
AVL-292 AVL-292 |
10mM in DMSO |
|
|
阿法埃莎 | C46806-100MG | 100MG | 现货 | 1202757-89-8 |
斯比布鲁替尼,95% Spebrutinib, 95% |
|
|
|
毕得 | BD328411-50mg | 50mg | 现货 | 1202757-89-8 |
N-(3-((5-氟-2-((4-(2-甲氧基乙氧基)苯... N-(3-((5-Fluoro-2-((4-(2-met... |
98+% |
|
|
毕得 | BD328411-100mg | 100mg | 现货 | 1202757-89-8 |
N-(3-((5-氟-2-((4-(2-甲氧基乙氧基)苯... N-(3-((5-Fluoro-2-((4-(2-met... |
98+% |
|
|
毕得 | BD328411-250mg | 250mg | 现货 | 1202757-89-8 |
N-(3-((5-氟-2-((4-(2-甲氧基乙氧基)苯... N-(3-((5-Fluoro-2-((4-(2-met... |
98+% |
|
|